Literature DB >> 31665765

Higher naloxone dosing may be required for opioid overdose.

Russell Bardsley1.   

Abstract

PURPOSE: Carfentanil is a synthetic opioid with an estimated potency that is 10,000 times more than that of morphine and 100 times more than that of fentanyl. Although there is a paucity of evidence, when considering the potency of carfentanil, it is reasonable to speculate that larger doses of naloxone may be required to resuscitate patients after carfentanil ingestion. This case report discusses the use of high-dose naloxone in 2 patients with suspected carfentanil overdose presenting to a small community hospital.
SUMMARY: Two patients with suspected carfentanil overdose presented to a 30-bed emergency department at a community hospital in New Hampshire. Cyanosis and respiratory distress were noted in both instances, and airway intervention was ultimately deemed necessary. Patient 1 required a total of 12 mg of naloxone to be successfully resuscitated, while patient 2 required a total of 10 mg for resuscitation. Both patients were successfully resuscitated with high doses of naloxone. The use of high-dose naloxone prevented the need for intubation in these patients.
CONCLUSION: While more robust studies should be considered, emergency personnel should be comfortable using higher-than-standard doses of naloxone in appropriate cases. © American Society of Health-System Pharmacists 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  carfentanil; fentanyl; heroin; naloxone; overdose

Mesh:

Substances:

Year:  2019        PMID: 31665765     DOI: 10.1093/ajhp/zxz208

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  5 in total

1.  Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study.

Authors:  Stephen Parkin; Joanne Neale; Caral Brown; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer
Journal:  Int J Drug Policy       Date:  2020-04-15

2.  Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.

Authors:  Joanne Neale; Nicola J Kalk; Stephen Parkin; Caral Brown; Laura Brandt; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer
Journal:  J Subst Abuse Treat       Date:  2020-08-05

Review 3.  Treatment of opioid overdose: current approaches and recent advances.

Authors:  Stevie C Britch; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2022-04-07       Impact factor: 4.530

4.  A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.

Authors:  Stephen Parkin; Joanne Neale; Caral Brown; Jermaine D Jones; Laura Brandt; Felipe Castillo; Aimee N C Campbell; John Strang; Sandra D Comer
Journal:  Int J Drug Policy       Date:  2020-10-20

5.  The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys.

Authors:  Peter J H Scott; Robert A Koeppe; Xia Shao; Melissa E Rodnick; Alexandra R Sowa; Bradford D Henderson; Jenelle Stauff; Phillip S Sherman; Janna Arteaga; Dennis J Carlo; Ronald B Moss
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.